medtech

This commercial med-tech is valued at just ~A$40m despite having innovative tech, market adoption and a partnership with a global giant.

ResMed (ASX:RMD) reported its June quarter and full year results after the U.S. market closed on Friday morning. The company met consensus expectations for both...

Don't sleep on this alternative treatment to CPAP in the massive and growing obstructive sleep apnea market

The medtech landscape is rife with fast growing companies typically operating in oligopolistic industry structures that drive profitability.

On Wednesday 23 August, Curvebeam AI (ASX: CVB) was listed on the ASX. The market for this kind of company remains hostile: biotech indices are close to their lows and...

During a once-in-a-century global pandemic perhaps counterintuitively one of the most affected sectors was the medical device manufacturers. Weighed down by...

The healthcare sector is not homogeneous, its companies and sub-sectors are diverse. In contrast, the business activities and products of most banks look similar and...

Themes around secular growth are widely covered by the media, but they often focus on the consumer-facing companies that dominate a particular...